Michael Halstead is President of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 0 shares of ITCI, which is worth approximately $0. The most recent transaction as insider was on Nov 17, 2020, when has been sold 75,000 shares (Common Stock) at a price of $13.86 per share, resulting in proceeds of $1,039,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Michael Halstead Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2020
BUY
Exercise of conversion of derivative security
$1,039,500 $13.86 p/Share
75,000 Added 48.57%
79,425 Common Stock
MH

Michael Halstead

President
New York, NY

Track Institutional and Insider Activities on ITCI

Follow Intra-Cellular Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

News

Receive news related to Intra-Cellular Therapies, Inc.

Track Activities on ITCI